Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Green Fresh Biotechnology Co's PEG Ratio or its related term are showing as below:
During the past 10 years, Green Fresh Biotechnology Co's highest PEG Ratio was 2.78. The lowest was 0.21. And the median was 0.76.
HKSE:01084's PEG Ratio is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 1.34 * Ranked among companies with meaningful PEG Ratio only.
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Green Fresh Biotechnology Co (HKSE:01084) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Green Fresh Biotechnology Co PEG Ratio Related Terms
Green Fresh Biotechnology Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Farm Products subindustry, Green Fresh Biotechnology Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Fresh Biotechnology Co PEG Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Green Fresh Biotechnology Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Green Fresh Biotechnology Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Is Green Fresh Biotechnology Co (HKSE:01084) Overvalued in 2026?
Based on GuruFocus' analysis, Green Fresh Biotechnology Co stock appears to be overvalued.
The current stock price of HK$0.68 is trading 23.6% above its estimated GF Value™ of HK$0.55.
GuruFocus considers Green Fresh Biotechnology Co to be Modestly Overvalued.
Key valuation signals for HKSE:01084:
PEG Ratio: N/A
GF Value™: HK$0.55 vs. price of HK$0.68 (23.6% above fair value)
No single metric tells the full story. See the HKSE:01084 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Fresh Biotechnology Co Ltd, formerly Green Future Food Hydrocolloid Marine Science Co Ltd is engaged in manufacturing and sales of food manufacturing hydrocolloid products including carrageenan products, agar-agar products, blended products, and konjac products in the People's Republic of China and overseas. Its segments include Manufacturing and sales of agar-agar products, which derives maximum revenue; Manufacturing and sales of carrageenan; Manufacturing and sales of konjac products; Manufacturing and sales of blended products; and Others, such as trading of seaweed powder and other operations. Its operations are spread across Chinese Mainland, which derives maximum revenue; Europe; Asia (excluding Chinese Mainland); South America; North America; Africa; and Oceania.
52GF Score
Get the complete analysis for HKSE:01084
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01084 has been successfully added to your 
